mCig, Inc. Announces New Product Launch of Ultra-Pure CBD Hemp Vape

mCig® Inc., a leading provider of advanced technologies and solutions to the global cannabis industry, is excited to announce the official start of CBD product line releases and the launch of a new website specifically geared for vaporizer users at: www.justCBDoil.com. mCig is unveiling its new CHILL! Just CBD Oil Vape Pen at the Academy Awards Celebrity Gift Suite, where the product, along with accessory kits will be handed out to A-list celebrity guests and awards nominees for sampling Sat., February 21st.

Derived from industrial hemp grown in Europe, mCig procures only the finest CBD in the world which undergoes extensive and rigorous purity testing. mCig, Inc.’s CBD products are assembled and manufactured in the USA by approved and registered FDA facilities, and lab tested again for quality assurance. The Company is preparing for the vast market opportunities ahead with CBD products, retail and wholesale distributions, and supply chain acquisitions to rapidly increase revenues and shareholder value.

The new product named CHILL! by justCBDoil.com is a revolutionary ultra-pure formula and patent-pending e-liquid that produces a maximum CBD effect unlike anything else currently available. mCig, Inc. has partnered with Just Chill Products, LLC in Melbourne, Florida to manufacture and distribute a new-to-market CBD Hemp Oil formula, initially released in prefilled tanks. Just CBD Oil’s CHILL! Prefilled Tank is ready-made for the popular mCig 2.x model vaporizer device and fits any universal 510 threaded battery. Natural flavorings, larger tank sizes, and sleek new vape pens are also scheduled for upcoming release on www.justCBDoil.com.

“The response to this specific breakthrough CBD Hemp Oil formulation has been overwhelming and we anticipate record sales, reinforced with high reorder rates on www.justCBDoil.com, the exclusive online retail site for our new CBD vape e-liquid. mCig, Inc.’s quality CBD products are 100% legal in all 50 states and over 40 countries, ready for retail shelves, and we are actively pursuing multiple distribution agreements. mCig Inc. is gearing towards success as we continue to build our brand and expand our revenue streams,” said Paul Rosenberg, mCig CEO.

About mCig, Inc.

Headquartered in Beverly Hills, CA, mCig, Inc. is a leading provider of advanced technologies and solutions to the global cannabis industry. mCig manufactures and markets best-selling portable and home vaporizers, extraction related equipment, CBD Rich Hemp Oil-derived products, and related nutraceuticals based on natural compounds found in Cannabis and Hemp plants. The company owns the mCig and Vapolution brands, and has a 47% stake in VitaCig (VTCQ), makers of the VitaStik, a disposable vitamin vaporizer. The company believes that a well-regulated marijuana industry is emerging as more states follow the lead of Alaska, Colorado, Oregon, and Washington in legalizing marijuana. A similar trend is developing within the CBD and Hemp industries following overwhelming consumer demand.

Safe Harbor Statement

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company’s ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company’s products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company’s business, research, product development, regulatory approval, marketing and distribution plans and strategies.